Remission hope and blood test for Type 2 Diabetes

Goodbody Health

Professor Roy Taylor has announced the results of his ReTUNE study, funded by Diabetes UK, showing for the first time that remission of type 2 diabetes is possible for people with lower bodyweights through a structured low-calorie diet programme.

The DiRECT results will hopefully inspire people living with overweight or obesity and a recent diagnosis of type 2 diabetes to lose weight and go into remission. This means that their blood sugars are in the normal range and they no longer have to take medication for their diabetes.

The NHS England low-calorie diet programme, like the DiRECT trial, involves replacing usual foods, for a short time, with nutritionally balanced, low-calorie ‘soup and shake’ products. This is now being offered in 21 areas across England. The team leading the NewDAWN research programme recognise it’s important to find a diet that is safe, effective and suitable to individual needs. The aim is to develop a new nationwide NHS support service that offers a range of weight loss diets for people with overweight or obesity and newly diagnosed with type 2 diabetes.

Marc Howells, CEO of Goodbody Health, commented, “The results of this ground breaking trial will give hope to many that are suffering with this serious condition. In line with the guidance from the UK Diabetes association and the NHS, we’d encourage people to get their blood tested at the pre-diabetes stage, in order to make the necessary changes to their lifestyle, as early as possible. There are now more options than ever for people to manage their health care digitally and Goodbody are proud to be at the forefront of that change for individuals and their local communities.”  

Know More. Live Better. Goodbody Health provides healthcare testing services in the local community. 

The Goodbody Health Group Inc. is listed on the Canadian Securities Exchange (CSE), the Aquis Stock Exchange – Growth Market (AQSE) Apex segment, OTC Pink, and Frankfurt Stock Exchange (FSE), providing current and prospective shareholders with multiple platforms in which to buy and sell Goodbody Health Group Inc. stock under the EPIC codes: CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: GDBYF).

You might also enjoy reading  Goodbody Health business fundamentals have never been better (AQSE:GDBY)
Find more news, interviews, share price & company profile here for:
Goodbody Health

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit
Find more news, interviews, share price & company profile here for:
Goodbody Health

AIM All Share Index